MedTech News
.................... by Andrew Celentano
Engineered antibodies offer broad protection against deadly cobra toxins
A research team has developed a recombinant, nanobody-based antivenom that offers broad protection against venom from geographically diverse cobra and king cobra species in India. The study is published in Science Translational Medicine and includes researchers at the Centre for Ecological Sciences (CES), Indian Institute of Science (IISc), and collaborators at the Technical University of Denmark (DTU).
Pancreatic tumors use clotting pathway to build immune shields, study finds
Researchers at the Icahn School of Medicine at Mount Sinai have found that small populations of pancreatic cancer cells can create localized immune-protective niches that shield tumors from immune attack. The finding could open new avenues for making immunotherapy more effective against one of the deadliest forms of cancer.
Wound-healing peptides curb bacterial colonization in cystic fibrosis airway models
Cystic fibrosis, one of the most common genetic diseases in Switzerland, promotes chronic bacterial infections by impairing the protective barrier of the airways. Scientists at the University of Geneva (UNIGE) have discovered that this dysfunction is caused by the abnormal activation of a protein, connexin 43, which disrupts cellular organization and compromises the integrity of the airways.
AI virtual cell uses protein dynamics to predict personalized breast cancer treatments
Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments. A new AI tool called ProteinTalks makes this task easier by accurately predicting whether a drug will be effective against a cancer cell line, finding new drug combinations and identifying proteins linked to drug resistance.
LifeTech Scientific Receives CE MDR Certification for Yuranos Abdominal Aortic Stent Graft System
LifeTech Scientific, a Shenzhen, China-based developer of advanced minimally invasive medical devices for cardiovascular diseases and disorders, has received CE MDR certification for its self-developed Yuranos abdominal aortic stent graft system, which is indicated for endovascular repair of infrarenal abdominal aortic aneurysms and can be used in combination with the company’s G-iliac iliac bifurcation stent system and SilverFlow iliac artery covered stent system
Senphonix secures NSF grant for SleeveSense wearable development
The grant will assist Senphonix and the University of Arizona in their efforts to strengthen the device’s wireless components.
XCath secures FDA breakthrough designation for remote thrombectomy robot
With the FDA designate in hand, XCath will further the development of its system that is intended to broaden access to stroke treatment globally.
Nutromics’ drug monitoring patch secures FDA breakthrough designation
Breakthrough designation for Nutromics’ namesake patch applies to the wearable platform’s function in vancomycin drug monitoring.